Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jan 19;26(1):1-8.
doi: 10.3727/096504016X14772410356982. Epub 2017 Nov 29.

miR-644a Inhibits Cellular Proliferation and Invasion via Suppression of CtBP1 in Gastric Cancer Cells

Affiliations

miR-644a Inhibits Cellular Proliferation and Invasion via Suppression of CtBP1 in Gastric Cancer Cells

Yingchao Li et al. Oncol Res. .

Abstract

Epithelial-mesenchymal transition (EMT) is one of the most important mechanisms in the metastasis of various cancers, including gastric cancer (GC). In this study, we explored the putative significance of miR-644a and its role in EMT-mediated metastasis of GC. We first detected the expression of miR-644a in a cohort of 107 GC tissues using quantitative RT-PCR. The expression of miR-644a was suppressed in GC tissues and was associated with a later clinical stage and tumor metastasis. Restoring the expression of miR-644a could significantly suppress the migration and invasion of HGC-27 and SGC-7901 cells, which might be correlated to its suppressive effect on the EMT process. We also found that carboxyl-terminal-binding protein 1 (CtBP1) was a putative target gene of miR-644a in GC and might be involved in the suppressive effect. Collectively, through targeting CtBP1-mediated suppression of the EMT process, miR-644a might suppress the tumor metastasis of GC cells.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Expression level of miR-644a in gastric cancer tissues. (A) The expression level of miR644a was detected in 107 pairs of GC tissues using TaqMan quantitative RT-PCR. Data are shown as log10 of relative ratio change of esophageal cancer tissues relative to normal tissues. (B) The mean level of miR-644a expression in GC cancerous and noncancerous tissues. The expression of miR-644a was suppressed in GC tissues. (C, D) The expression of miR-644a was suppressed in cancer tissues in patients at a later clinical stage (stage III + IV vs. stage I + II) and metastasis. The expression of miR-644a was normalized to small nuclear RNA U6. **p < 0.01 compared with scramble group.
Figure 2
Figure 2
The effects of miR-644a on GC cell proliferation and invasion. (A) The level of miR-644a expression was detected in HGC-27 and SGC-7901 cells upon transfection with miR-644a or scramble mimic by quantitative RT-PCR. (B, C) The effects of miR-644a on cell migration and invasion of HGC-27 and SGC-7901 cells were performed by Transwell assay upon transfection with miR-644a. (Left) Cells passing through the chambers. (Right) The relative number of cells passing through per field. (D) A cell proliferation assay of GC cells was performed after transfection with miR-644a or scramble mimic by using CCK-8. (E) Western blot analysis of the expression of epithelial and mesenchymal marker proteins in GC cells transfected with miR-644a or scramble mimic was performed. Upon transfection, the epithelial marker E-cadherin was increased, and the mesenchymal markers vimentin and N-cadherin were suppressed. (F) Immunofluorescence assays further explored the expression of markers mentioned above. *p < 0.05, **p < 0.01 compared with the scramble group.
Figure 3
Figure 3
CtBP1 is a putative target gene of miR-644a in GC cells. (A) Schematic representation of CtBP1 3′-UTR showing the putative miR-644a target site. (B) A quantitative RT-PCR assay was performed to detect the expression of CtBP1 upon transfection with miR-644a or scramble mimic. (C) Relative luciferase activity of the indicated CtBP1 reporter construct in GC cells, cotransfected with miR-644a or scramble mimic, is shown. (D) Western blot analysis of the expression of CtBP1 protein in HGC-27 and SGC-7901 cells transfected with miR-644a or scramble mimic was performed. **p < 0.01 compared with the scramble group.
Figure 4
Figure 4
Knockdown of CtBP1 suppressed the proliferation and invasion of GC cells. (A) The level of CtBP1 mRNA expression was detected in HGC-27 and SGC-7901 cells upon transfection with si-CtBP1 and relative control. (B) The expression of CtBP1 protein level as well as relative markers was detected. The expression of CtBP1 and its downstream genes N-cadherin, as well as vimentin, was suppressed, while the expression of E-cadherin and β-catenin was upregulated. (C) The proliferation was suppressed upon transfection with si-CtBP1. (D) The invasion was suppressed upon transfection with si-CtBP1. **p < 0.01 compared with the scramble group.

References

    1. Gill RS, Al-Adra DP, Nagendran J, Campbell S, Shi X, Haase E, Schiller D. Treatment of gastric cancer with peritoneal carcinomatosis by cytoreductive surgery and HIPEC: A systematic review of survival, mortality, and morbidity. J Surg Oncol. 2011;104:692–8. - PubMed
    1. Christiansen JJ, Rajasekaran AK. Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res. 2006;66:8319–26. - PubMed
    1. Klymkowsky MW, Savagner P. Epithelial-mesenchymal transition: A cancer researcher’s conceptual friend and foe. Am J Pathol. 2009;174:1588–93. - PMC - PubMed
    1. Zhao L, Li W, Zang W, Liu Z, Xu X, Yu H, Yang Q, Jia J. JMJD2B promotes epithelial-mesenchymal transition by cooperating with beta-catenin and enhances gastric cancer metastasis. Clin Cancer Res. 2013;19:6419–29. - PubMed
    1. Ryu HS, Park do J, Kim HH, Kim WH, Lee HS. Combination of epithelial-mesenchymal transition and cancer stem cell-like phenotypes has independent prognostic value in gastric cancer. Hum Pathol. 2012;43:520–8. - PubMed

MeSH terms